Conference - Singapore
‘’Emphasis by Southeast Asian countries on economic growth through increased R&D investments is likely to continue through the end of the decade’’ – Battellle, Dec 2013The up and coming Southeast Asian countries are poised to become the next big pharmaceutical emerging markets after China and India. IBC Asia’s Pharma R&D Asia conference brings together pharmaceutical stakeholders, government, CROs, academia, finance, investors and other key stakeholders to engage in discussions on the Asian pharmaceutical R&D industry, strategic partnerships, collaboration and innovation to grow Asia’s competitiveness in pharmaceutical R&D.
Key Themes in 2014
» Regulatory trends and their impact on pharma R&D
» Clinical trial development and requirements
» R&D investment, partnership and collaboration opportunities in Asia
» Intellectual property rights
» Clinical infrastructure and Operations
» Developing, retaining and attracting scientific talent for Asian R&D growth
» Outsourcing and insourcing
» Venture capital options and incentives
Organization: IBC Asia (S) Pte Ltd
Tue, Aug 26, 2014 - Fri, Aug 29, 2014
PARKROYAL on Beach Road
7500 Beach Road, Singapore 199591, Singapore
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
